Mispro expands vivarium capacity, sees ‘tremendous potential’

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/gemenacom)
(Image: Getty/gemenacom)

Related tags: facility, Biotech hub, New york city, Life sciences companies, Industry

Mispro is expanding its vivarium service network with the opening of its fifth facility, an 18,000 square foot facility in Broad Hollow Bioscience Park, NY.

The preclinical biotech services company provides vivarium operations and services through its network of facilities outside of New York, in Cambridge, MA, Research Triangle Park, NC, and Montreal, Canada – all of which Mispro said are ‘key biotech and life science clusters.’

This new facility 18,000 square foot facility in Broad Hollow Bioscience Park, NY will be the company’s second in the state after it opened a facility in Manhattan in 2010.

Providing vivarium operations, the company supports clients with access to research and animal housing space as well as animal care, regulatory, and compliance services.

Philippe Lamarre, CEO of Mispro Biotech Services, said in a statement that within 25 miles of the facility there are established biopharma organizations and incubators, as well as a growing amount of early-stage biotechs. Farmingdale, New York, home to Broad Hollow Bioscience park is around 40 miles East of Manhattan.

Lamarre told us that with the new facility the company has the opportunity to provide space to the surrounding research community as well as companies headquartered in New York city that need more space or are getting priced out. 

 “At our very best, we are a catalyst for early-stage companies, enabling them to launch and control their own studies relative to their funding, which we believe will produce increased innovation in therapeutic drug development,”​ said LaMarre. He added that Mispro is currently seeing ‘tremendous potential’ in its ability to serve the industry.

The company also has plans to expand into Europe in later 2019 and early 2020.

Related news

Show more

Related products

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more